Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to determine if thin endometrial lining that is unresponsive to estrogen might be associated with the presence of senescent cells in patients following long-term use of oral contraceptives. The main question it aims to answer is: Are there any senescent cells present in thin endometrial lining? During the luteal phase of the cycle, participants will will undergo: - Gynecologic US to measure the endometrial lining thickness and pattern. - Endometrial biopsy with Pipelle catheter


Clinical Trial Description

The investigators hypothesized that senescent cells in the endometrium may be the cause of the failure of thin endometrium to respond to normal growth stimuli such as estrogen. The outcome that research team anticipate to measure is the percentage of senescent cells in the endometrial biopsies of women with thin endometrium compared to the control group biopsies. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06450301
Study type Observational
Source Trio Fertility
Contact
Status Recruiting
Phase
Start date June 2024
Completion date June 2027

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03223454 - Human Amniotic Epithelial Cells for Asherman's Syndrome Phase 1
Terminated NCT02825849 - Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair Phase 2
Completed NCT02708277 - Reproductive Outcome Affected by Two Adjunctive Treatments in Patients With Severe Intrauterine Adhesions N/A
Completed NCT02144987 - Bone Marrow Stem Cell Treatment for Asherman's Syndrome and Endometrial Atrophy Phase 4